Trial Profile
An Open Label, Randomized, 2-sequence, 2-period, Single-dose Cross-over Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Besifovir (Primary)
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Ildong Pharmaceutical
- 12 Jan 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2014 New trial record